Skip to content

← All news

Markets

Baird raises Climb Bio stock price target to $25 on trial data

1 source ·2 articles ·Sep 3, 18:08 UTC Climb Bio

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·Sep 3, 18:08 UTC

BTIG raises Climb Bio stock price target to $32 on phase 1 data

Investing.com UK ·Sep 3, 17:04 UTC

Baird raises Climb Bio stock price target to $25 on trial data